Cavernoma Treatment in Turkey

What is a cavernoma and what are the symptoms?

A cavernoma, also called a cavernous haemangioma or cerebral cavernous malformation (CCM), is an abnormal cluster of dilated, thin-walled capillaries in the central nervous system. These abnormal blood vessels lack normal elastic tissue and smooth muscle, creating clusters of slow-flowing blood that resemble a small mulberry. Because their walls are fragile, cavernomas often leak microscopic amounts of blood into adjacent brain tissue, forming a surrounding ring of iron-containing haemosiderin.

Cavernomas can appear in the cerebral hemispheres, cerebellum, brainstem, or spinal cord. Many people have no symptoms, with the malformation detected unexpectedly on an MRI. When symptoms occur, they depend on lesion size, location, and previous micro-bleeding. Common symptoms include:

• Epileptic seizures: Frequently the primary symptom in cerebral lesions, caused by haemosiderin deposits irritating the cortex.
• Focal neurological deficits: Weakness, numbness, speech difficulties, or visual changes corresponding to the affected area.
• Recurrent headaches: Often throbbing or sudden, caused by local tissue irritation or minor bleeding.
• Balance problems: Unsteadiness, dizziness, or double vision, particularly when lesions occur in the cerebellum or brainstem.

How a cavernoma is diagnosed and assessed

Because cavernomas contain low-pressure, slow-moving blood, they are angiographically occult and rarely appear on conventional angiograms or routine CT scans without acute haemorrhage. Magnetic resonance imaging (MRI) is the definitive diagnostic tool. Hospitals in Turkey offering neurosurgery evaluate these malformations through specialised check-ups & diagnostics imaging protocols.

Diagnostic assessment typically relies on high-field MRI using specific sequences:

• T2-weighted and susceptibility-weighted imaging (SWI): Highlights haemosiderin staining, confirming the distinct "popcorn" appearance and detecting multiple or minute lesions.
• Diffusion tensor imaging (DTI): Maps nerve tracts near the lesion to guide surgical safety.
• Functional MRI (fMRI): Identifies critical speech, motor, or sensory areas in relation to the cavernoma.

Patients planning international medical evaluation should bring complete DICOM image files on disc or secure digital storage, rather than printed summary sheets alone. Providing detailed seizure logs, medication lists, and family medical histories is also essential, particularly because familial forms can present with multiple lesions that warrant paediatrics screening for relatives.

Treatment options and clinical indications

Care pathways depend on lesion location, bleeding history, neurological symptoms, and overall health. Clinical decisions are made by the treating neurosurgeon following full evaluation. Many stable or incidental cavernomas require only regular monitoring rather than surgery.

Planning cavernoma treatment in Turkey

Organising neurosurgical treatment abroad requires structured planning. International patients usually begin with a comprehensive remote review of their recent MRI scans by a Turkish neurosurgical specialist. This review determines whether surgery is appropriate or if continued surveillance at home is preferable.

When intervention is indicated, patients typically need a stay of 10 to 14 days in Turkey. Inpatient care following elective microsurgery usually lasts between 3 and 7 days, including 24 to 48 hours in a neuro-intensive care unit. The remaining period is spent in local accommodation nearby for wound inspection, follow-up consultations, and post-operative imaging.

Before returning home, patients should obtain comprehensive discharge summaries, surgical notes, post-operative MRI discs, and clear medication instructions. Coordinating subsequent care with a domestic neurologist ensures seamless recovery, seizure management, and scheduled future scans.

When travel is not advisable and emergency warning signs

Air travel is unsafe if a patient has experienced recent intracranial bleeding, unstable neurological deterioration, or frequent uncontrolled seizures. While aircraft cabin pressure does not trigger haemorrhage, acute complications during flight pose extreme risks. Patients should only fly after achieving clinical stability and receiving direct clearance from their specialist.

Seek immediate emergency medical care locally if experiencing any of the following red-flag symptoms:

• Sudden, unusually severe headache of rapid onset.
• New or rapidly progressing weakness, facial droop, or limb numbness.
• Acute difficulty speaking, slurred speech, or loss of vision.
• New seizures, prolonged seizure activity, or lack of recovery between seizures.
• Persistent vomiting, profound drowsiness, or confusion.

In these situations, emergency assessment at your nearest local medical centre must always take precedence over international travel.